The gene calC encodes for a non-heme iron metalloprotein responsible for calicheamicin self-resistance in Micromonospora [9]

Journal of the American Chemical Society

Volumn 122, Issue 7, 2000, Pages 1556-1557

  Whitwam, Ross E ^a   Ahlert, Joachim ^a   Holman, Theodore R ^b   Ruppen, Mark ^c   Thorson, Jon S ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALICHEAMICIN; DOXORUBICIN; METALLOPROTEIN; NONHEME IRON PROTEIN;

ANTIBIOTIC RESISTANCE; AROMATIZATION; DRUG POTENCY; DRUG STRUCTURE; ELECTRON SPIN RESONANCE; GENE EXPRESSION REGULATION; GENE ISOLATION; GENE OVEREXPRESSION; HYDROLYSIS; LETTER; MICROMONOSPORA; NONHUMAN; RESTRICTION MAPPING;

MICROMONOSPORA;

EID: 0034000656     PISSN: 00027863     EISSN: None     Source Type: Journal    
DOI: 10.1021/ja993612w     Document Type: Letter

References (41)

1. For recent reviews see: (a) Thorson, J. S.; Sievers, E. L.; Ahlert, J.; Shepard, E.; Onwueme, K. C.; Ruppen, M. Curr. Pharm. Des. 2000, in press. (b) Thorson, J. S.; Shen, B.; Whitwam, R. E.; Liu, W.; Li, Y.; Ahlert, J. Bioorg. Chem. 1999, 27, 172-188. (c) Danishefsky, S. J.; Shair, M. D. J. Org. Chem. 1996, 61, 16-44. (d) Enediyne Antibiotics as Antitumor Agents; Marcel Dekker: New York, 1995. (e) Nicolaou, K. C.; Smith, A. L.; Yue, E. W. Proc. Natl. Acad. Sci. U.S.A. 1993, 90, 5881-5888. (f) Nicolaou, K. C.; Dai, W.-M. Angew. Chem., Int. Ed. Engl. 1991, 30, 1387-1416.
2. For recent reviews see: (a) Thorson, J. S.; Sievers, E. L.; Ahlert, J.; Shepard, E.; Onwueme, K. C.; Ruppen, M. Curr. Pharm. Des. 2000, in press. (b) Thorson, J. S.; Shen, B.; Whitwam, R. E.; Liu, W.; Li, Y.; Ahlert, J. Bioorg. Chem. 1999, 27, 172-188. (c) Danishefsky, S. J.; Shair, M. D. J. Org. Chem. 1996, 61, 16-44. (d) Enediyne Antibiotics as Antitumor Agents; Marcel Dekker: New York, 1995. (e) Nicolaou, K. C.; Smith, A. L.; Yue, E. W. Proc. Natl. Acad. Sci. U.S.A. 1993, 90, 5881-5888. (f) Nicolaou, K. C.; Dai, W.-M. Angew. Chem., Int. Ed. Engl. 1991, 30, 1387-1416.
3. For recent reviews see: (a) Thorson, J. S.; Sievers, E. L.; Ahlert, J.; Shepard, E.; Onwueme, K. C.; Ruppen, M. Curr. Pharm. Des. 2000, in press. (b) Thorson, J. S.; Shen, B.; Whitwam, R. E.; Liu, W.; Li, Y.; Ahlert, J. Bioorg. Chem. 1999, 27, 172-188. (c) Danishefsky, S. J.; Shair, M. D. J. Org. Chem. 1996, 61, 16-44. (d) Enediyne Antibiotics as Antitumor Agents; Marcel Dekker: New York, 1995. (e) Nicolaou, K. C.; Smith, A. L.; Yue, E. W. Proc. Natl. Acad. Sci. U.S.A. 1993, 90, 5881-5888. (f) Nicolaou, K. C.; Dai, W.-M. Angew. Chem., Int. Ed. Engl. 1991, 30, 1387-1416.
4. For recent reviews see: (a) Thorson, J. S.; Sievers, E. L.; Ahlert, J.; Shepard, E.; Onwueme, K. C.; Ruppen, M. Curr. Pharm. Des. 2000, in press. (b) Thorson, J. S.; Shen, B.; Whitwam, R. E.; Liu, W.; Li, Y.; Ahlert, J. Bioorg. Chem. 1999, 27, 172-188. (c) Danishefsky, S. J.; Shair, M. D. J. Org. Chem. 1996, 61, 16-44. (d) Enediyne Antibiotics as Antitumor Agents; Marcel Dekker: New York, 1995. (e) Nicolaou, K. C.; Smith, A. L.; Yue, E. W. Proc. Natl. Acad. Sci. U.S.A. 1993, 90, 5881-5888. (f) Nicolaou, K. C.; Dai, W.-M. Angew. Chem., Int. Ed. Engl. 1991, 30, 1387-1416.
5. For recent reviews see: (a) Thorson, J. S.; Sievers, E. L.; Ahlert, J.; Shepard, E.; Onwueme, K. C.; Ruppen, M. Curr. Pharm. Des. 2000, in press. (b) Thorson, J. S.; Shen, B.; Whitwam, R. E.; Liu, W.; Li, Y.; Ahlert, J. Bioorg. Chem. 1999, 27, 172-188. (c) Danishefsky, S. J.; Shair, M. D. J. Org. Chem. 1996, 61, 16-44. (d) Enediyne Antibiotics as Antitumor Agents; Marcel Dekker: New York, 1995. (e) Nicolaou, K. C.; Smith, A. L.; Yue, E. W. Proc. Natl. Acad. Sci. U.S.A. 1993, 90, 5881-5888. (f) Nicolaou, K. C.; Dai, W.-M. Angew. Chem., Int. Ed. Engl. 1991, 30, 1387-1416.
6. For recent reviews see: (a) Thorson, J. S.; Sievers, E. L.; Ahlert, J.; Shepard, E.; Onwueme, K. C.; Ruppen, M. Curr. Pharm. Des. 2000, in press. (b) Thorson, J. S.; Shen, B.; Whitwam, R. E.; Liu, W.; Li, Y.; Ahlert, J. Bioorg. Chem. 1999, 27, 172-188. (c) Danishefsky, S. J.; Shair, M. D. J. Org. Chem. 1996, 61, 16-44. (d) Enediyne Antibiotics as Antitumor Agents; Marcel Dekker: New York, 1995. (e) Nicolaou, K. C.; Smith, A. L.; Yue, E. W. Proc. Natl. Acad. Sci. U.S.A. 1993, 90, 5881-5888. (f) Nicolaou, K. C.; Dai, W.-M. Angew. Chem., Int. Ed. Engl. 1991, 30, 1387-1416.
7. When evaluated in p388 and B16 animal models (see ref 3a).
8. (a) Lee, M. D. Enediyne Antibiotics as Antitumor Agents; Marcel Dekker: New York, 1995; pp 49-74.
9. (b) Zein, N.; Sinha, A. M.; McGaharen, W. J.; Ellestad, G. A. Science 1988, 240, 1198-1201.
10. (a) Ellestad, G. A.; Ding, W.-D.; Zein, N.; Townsend, C. A. Enediyne Antibiotics as Antitumor Agents; Marcel Dekker: New York, 1995; pp 137-160.
11. (b) Drak, J.; Iawasawa, S.; Danishefsky, S.; Crothers, D. Proc. Natl. Acad. Sci. U.S.A. 1991, 88, 7464.
12. (c) Ding, W.-d; Ellestad, G. A. J. Am. Chem. Soc. 1991, 113, 6617.
13. (d) Walker, S.; Yang, D.; Kahne, D.; Gange, D. J. Am. Chem. Soc. 1991, 113, 4716-4717.
14. McGahren, W. J.; Ding, W.-D.; Ellestad, G. A. Enediyne Antibiotics as Antitumor Agents; Marcel Dekker: New York, 1995; pp 75-86.
15. (a) Sievers, E. L.; Appelbaum, F. R.; Spielberger, R. T.; Forman, S. J.; Flowers, D.; Smith, F. O.; Shannon-Dorcy, K.; Berger, M. S.; Bernstein, I. D. Blood 1999, 93, 3678-3684.
16. (b) Hinman, L. M.; Hamann, P. R.; Upeslacis, J. Enediyne Antibiotics as Antitumor Agents; Marcel Dekker: New York, 1995; pp 87-105.
17. (c) Hinman, L. M.; Hamann, P. R.; Wallace, R.; Menendez, A. T.; Durr, F. E.; Upeslacis, J. Cancer Res. 1993, 53, 3336.
18. Rothstein, D. M. Enediyne Antibiotics as Antitumor Agents; Marcel Dekker: New York, 1995; pp 107-126.
19. -1 ampicillin in E. coli are as follow: cosmids 3a, 4a, 4b, 10a, 13a, and 16a, 0.5; pJT1214 and pJT1232, 5.0; pRE7, 20.0; induced pRE7, 50.0; and pJT1224, pAP6, pRE1, and control plasmids pUC18, pBluescript, and pMAL-C2, <0.01. Given that the cosmid clones which carry calC are known to carry both polyketide synthase and deoxy sugar genes, this work also verifies that we have cloned the 1 biosynthetic gene cluster (Whitwam, R. E.; Ahlert, J.; Shepard, E.; Thorson, J. S., unpublished results).
20. 8
21. 9
22. -1). The desired mbp-CalC was eluted with buffer A containing 10 mM maltose, concentrated, and resolved on S-300 (50 mM Tris·Cl, pH 7.5, 200 mM NaCl).
23. The precise mbp-CalC concentration was determined by quantitative amino acid hydrolysis by the Rockefeller University Protein/DNA Technology Center. Trace metal content of an aliquot of the hydrolysate was subsequently determined by ICP-MS on four distinct mbp-CalC preparations with buffer alone and/or maltose-binding protein alone, analyzed in parallel as controls. Results were independently confirmed by methodology for spectrophotometric Fe determination (Fish, W. W. Methods Enzymol. 1988, 158, 357-364).
24. Based upon the monomeric molecular weight of 63 576 calculated from the known nucleotide sequence of the mbp-calC gene fusion, which is consistent with the subunit molecular weight determined by SDS-PAGE.
25. Palmer, G. Biochem. Soc. Trans. 1985, 13, 548-560.
26. 3-fold excess of 1. Preincubation of mbp-CalC and DTT, protein removal via forced dialysis (Microcon-10), and the subsequent use of the DTT solution as reductant did not noticeably affect the amount of DNA cleavage.
27. 3+) prior to the activity assay; see ref 15.
28. (a) McManus, M. C. Am. J. Health-Syst. Pharm. 1997, 54, 1420-1433.
29. (b) Cundliffe, E. Self-Protection Mechanisms in Antibiotic Producers; Wiley: Chichester, 1992; pp 199-214.
30. (a) Lah, M. S.; Dixon, M. M.; Pattridge, K. A.; Stallings, W. C.; Fee, J. A.; Ludwig, M. L. Biochemistry 1995, 34, 1646-1660.
31. (b) Bull, C.; Fee, J. A. J. Am. Chem. Soc. 1985, 107, 3295-3304.
32. (c) Autor, A. P. J. Biol. Chem. 1982, 257, 2713-2718.
33. (d) Lavelle, F.; McAdam, M. E.; Fielden, E. M.; Roberts, P. B.; Puget, K.; Michelson, A. M. Biochem. J. 1977, 161, 3-11.
34. (e) McCord, J. M.; Fridovich, I. J. Biol. Chem. 1969, 244, 6049-6055.
35. (a) Lange, S. J.; Que, L., Jr. Curr. Opin. Chem. Biol. 1998, 2, 159-72.
36. (b) Prigge, S. T.; Boyington, J. C.; Faig, M.; Doctor, K. S.; Gaffney, B. J.; Amzel, L. M. Biochimie 1997, 79, 629-636.
37. (c) Solomon, E. I.; Zhou, J.; Neese, F.; Pavel, E. G. Chem., Biol. 1997, 4, 795-808.
38. (a) Sakata, N.; Kanbe, T.; Tanabe, M.; Hayashi,H.; Hori, M.; Hotta, K.; Hamada, M. J. Antibiot. 1989, XLII, 1704-1712.
39. (b) Sakata, N.; Mase, T.; Ikeno, S.; Hori, M.; Otani, T. J. Antibiot. 1993, 46, 1475-1477.
40. (a) Zein, N.; Schroeder, D. R. Adv. DNA Sequence-Specific Agents 1998, 3, 201-225.
41. (b) Zein, N.; Reiss, P.; Bernatowicz, M.; Bolgar, M. Chem. Biol. 1995, 2, 451-455.